Apotex agrees to pay $87.1 million to end payers, states in US generic drug suit
MLex Summary: Apotex agreed to pay third-party end-payers and certain state attorneys general $87.1 million to settle US price-fixing claims over generic pharmaceuticals. If approved, the end payers will receive $48...To view the full article, register now.
Already a subscriber? Click here to view full article